TLE1 as a Diagnostic Immunohistochemical Marker for Synovial Sarcoma Emerging From Gene Expression Profiling Studies

Synovial sarcoma is a soft tissue malignancy defined by the SYT-SSX fusion oncogene. Demonstration of the t(X;18) by cytogenetics, fluorescence in situ hybridization or reverse-transcriptase polymerase chain reaction has become the gold standard for diagnosis, but practical considerations limit the availability of these methods. Gene expression profiling studies performed by several independent groups have consistently identified TLE1 as an excellent discriminator of synovial sarcoma from other sarcomas, including histologically similar tumors such as malignant peripheral nerve sheath tumor. TLE proteins (human homologues of Groucho) are transcriptional corepressors that inhibit Wnt signaling and other cell fate determination signals, and so have an established role in repressing differentiation. We examined the expression of TLE proteins in synovial sarcoma and in a broad range of mesenchymal tumors using tissue microarrays to assess the value of anti-TLE antibodies in the immunohistochemical confirmation of synovial sarcoma. We demonstrate that TLE expression is a consistent feature of synovial sarcoma using both a well-characterized monoclonal antibody recognizing the TLE family of proteins and a commercially available polyclonal antibody raised against TLE1. Both antibodies gave intense and/or diffuse nuclear staining in 91/94 molecularly confirmed synovial sarcomas. Moderate staining is occasionally seen in schwannoma and solitary fibrous tumor/hemangiopericytoma. In contrast, TLE staining is detected much less frequently and at lower levels, if at all, in 40 other mesenchymal tumors. Our findings establish TLE as a robust immunohistochemical marker for synovial sarcoma, and may have implications for understanding the biology of synovial sarcoma and for developing experimental therapies for this cancer.

[1]  J. E. Eid,et al.  The synovial sarcoma translocation protein SYT-SSX2 recruits β-catenin to the nucleus and associates with it in an active complex , 2006, Oncogene.

[2]  R. Sciot,et al.  HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor , 2005, Modern Pathology.

[3]  P. Meltzer,et al.  Gene expression profiling of human sarcomas: insights into sarcoma biology. , 2005, Cancer research.

[4]  Neil Sebire,et al.  A molecular map of mesenchymal tumors , 2005, Genome Biology.

[5]  H. Inoue,et al.  Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo. , 2005, Cancer letters.

[6]  T. Nielsen,et al.  Effect of depsipeptide (NSC 630176), a histone deacetylase inhibitor, on human synovial sarcoma in vitro , 2005 .

[7]  Jefferson Terry,et al.  Fluorescence In Situ Hybridization for the Detection of t(X;18)(p11.2;q11.2) in a Synovial Sarcoma Tissue Microarray Using a Breakapart-Style Probe , 2005, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[8]  W. Weis,et al.  β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation , 2005, Nature Structural &Molecular Biology.

[9]  R. West,et al.  Nuclear beta-catenin in mesenchymal tumors , 2005, Modern Pathology.

[10]  P. Jayaraman,et al.  The Proline-rich Homeodomain Protein Recruits Members of the Groucho/Transducin-like Enhancer of Split Protein Family to Co-repress Transcription in Hematopoietic Cells* , 2004, Journal of Biological Chemistry.

[11]  R. West,et al.  Apo D in Soft Tissue Tumors: A Novel Marker for Dermatofibrosarcoma Protuberans , 2004, The American journal of surgical pathology.

[12]  B. Bui,et al.  Should molecular testing be required for diagnosing synovial sarcoma? , 2003, Cancer.

[13]  D. Botstein,et al.  Copyright © American Society for Investigative Pathology Tissue Microarray Validation of Epidermal Growth Factor Receptor and SALL2 in Synovial Sarcoma with Comparison to Tumors of Similar Histology , 2022 .

[14]  C. Chang,et al.  Molecular genetics of pediatric soft tissue tumors: clinical application. , 2003, The Journal of molecular diagnostics : JMD.

[15]  William Stafford Noble,et al.  Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. , 2003, The American journal of pathology.

[16]  M. Bittner,et al.  Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. , 2002, The American journal of pathology.

[17]  L. Guillou,et al.  Monophasic Fibrous and Poorly Differentiated Synovial Sarcoma: Immunohistochemical Reassessment of 60 t(X;18)(SYT-SSX)-Positive Cases , 2002, The American journal of surgical pathology.

[18]  Yusuke Nakamura,et al.  Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. , 2002, Cancer research.

[19]  D. Botstein,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[20]  S. Stifani,et al.  Role for Hes1-Induced Phosphorylation in Groucho-Mediated Transcriptional Repression , 2002, Molecular and Cellular Biology.

[21]  M. Ladanyi Fusions of the SYT and SSX genes in synovial sarcoma , 2001, Oncogene.

[22]  D. Ayer,et al.  Pf1, a Novel PHD Zinc Finger Protein That Links the TLE Corepressor to the mSin3A-Histone Deacetylase Complex , 2001, Molecular and Cellular Biology.

[23]  H Clevers,et al.  All Tcf HMG box transcription factors interact with Groucho-related co-repressors. , 2001, Nucleic acids research.

[24]  A. V. van Kessel,et al.  Molecular mechanisms underlying human synovial sarcoma development , 2001, Genes, chromosomes & cancer.

[25]  A. Courey,et al.  Groucho/TLE family proteins and transcriptional repression. , 2000, Gene.

[26]  R. Lo,et al.  Disrupted development of the cerebral hemispheres in transgenic mice expressing the mammalian Groucho homologue Transducin-like-Enhancer of split 1 in postmitotic neurons , 2000, Mechanisms of Development.

[27]  M. Ladanyi,et al.  Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. , 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[28]  J. Fernández,et al.  A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. , 1999, Genes & development.

[29]  A. Gown,et al.  Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. , 1998, The American journal of surgical pathology.

[30]  C. Fisher Synovial sarcoma. , 1998, Annals of diagnostic pathology.

[31]  R. Lo,et al.  Affinity for the nuclear compartment and expression during cell differentiation implicate phosphorylated Groucho/TLE1 forms of higher molecular mass in nuclear functions. , 1996, The Biochemical journal.

[32]  Stefano Stifani,et al.  Human homologs of a Drosophila Enhancer of Split gene product define a novel family of nuclear proteins , 1992, Nature Genetics.

[33]  R. Golouh,et al.  Synovial sarcoma: A clinicopathological study of 36 cases , 1990, Journal of surgical oncology.